SF3B1 and myelodysplastic syndrome: Altered RNA splicing has been suggested as the mechanism underlying the observed phenotypic changes concomitant to splicing factor gene mutations, including SF3B1; 3, 12, 13 however, the target genes in the HSC of MDS cases with SF3B1 mutations are yet to be defined.